Cart
sales@molnova.com
1-(2-hydroxyethyl)thymine
CAS No. 22441-51-6
1-(2-hydroxyethyl)thymine( —— )
Catalog No. M37819 CAS No. 22441-51-6
1-(2-hydroxyethyl)thymine (2,4(1H,3H)-Pyrimidinedione, 1-(2-hydroxyethyl)-5-methyl-) is a marine derived natural products found in Zoanthus sp.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 329 | In Stock |
|
| 2MG | 278 | In Stock |
|
| 5MG | 425 | In Stock |
|
| 10MG | 626 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1283 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-(2-hydroxyethyl)thymine
-
NoteResearch use only, not for human use.
-
Brief Description1-(2-hydroxyethyl)thymine (2,4(1H,3H)-Pyrimidinedione, 1-(2-hydroxyethyl)-5-methyl-) is a marine derived natural products found in Zoanthus sp.
-
Description1-(2-hydroxyethyl)thymine (2,4(1H,3H)-Pyrimidinedione, 1-(2-hydroxyethyl)-5-methyl-) is a marine derived natural products found in Zoanthus sp.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22441-51-6
-
Formula Weight170.17
-
Molecular FormulaC7H10N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CO)N1C(=O)NC(=O)C(C)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Aleuritic Acid
Aleuritic acid, or α-aleuritic acid, is a major ingredient in shellac, constituting about 35% of it. It is used as a starting material in the perfume industry for the preparation of musk aroma.
-
Nile Red
Nile Red is a strongly fluorescent stain used for the detection of intracellular lipid droplets in the presence of a hydrophobic environment.
-
Linzagolix
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.
